After a sharp uptick the previous week, the Indian startup funding ecosystem witnessed a dramatic pullback in momentum. Between May 12 and 17, Indian startups raised a total of $151.6 million across 24 deals, a massive 74% drop from the $587 million raised by 27 startups just a week earlier. The primary reason? A lack of large-ticket deals that had propelled the previous week’s numbers.
Funding Dips Amid Absence of Mega Deals
The sharp decline in total funding was primarily attributed to the absence of mega funding rounds. In contrast to the $218 million raised by PB Health last week, the largest cheque this week was $40 million, secured by D2C snacking brand Farmley in a Series C round led by L Catterton.
Apart from Farmley, notable fundraises included $16 million raised by healthtech startup Complement1, $15 million by Celebal (a horizontal SaaS player), and $14 million by AR-led media startup Flam. Still, these couldn’t match the momentum of previous week’s headline-grabbing numbers.
Ecommerce and Enterprise Tech Lead the Pack
With Farmley leading the charge, ecommerce emerged as the most funded sector, drawing $54.9 million across four startups. Close behind was enterprise tech, which also saw four deals totaling $22.2 million. Other active sectors included healthtech, fintech, and cleantech.
Among the ecommerce players, BlueStone raised $4.7 million in debt, while Hocco drew $10 million in a Series B round. In enterprise tech, startups like Adopt AI, Third Bracket, and ContraVault AI secured early-stage funding from a mix of institutional and angel investors.
Seed Funding Sees a Sharp Fall
A major contributor to the week’s funding slowdown was the steep drop in seed-stage investments. Only $29.8 million was raised by 11 seed-stage startups, compared to $227.4 million last week. Investors likely adopted a more cautious stance after last week’s surge, focusing on select bets rather than spreading capital across numerous early-stage ventures.
Active investors during the week included IvyCap Ventures and Titan Capital, each backing two startups. Titan participated in Be Clinical and ContraVault AI, while IvyCap backed Avammune Therapeutics and TIEA Connectors.
IPO Buzz: Groww, Curefoods, Moneyview in Spotlight
Even as private capital flows dipped, activity on the IPO front picked up steam. Investment platform Groww is planning to file a confidential DRHP in the coming weeks for an IPO that may value the company between $7–8 billion. Additionally, Curefoods converted into a public entity as it works toward a ₹1,500 Cr IPO.
Meanwhile, fintech unicorn Moneyview has reportedly roped in Axis Capital and Kotak Mahindra Capital as bankers for its $400 million IPO.
VC Fund Launches & Strategic Moves
Despite the funding slowdown, venture capital activity remained lively. Former Twitter India head Manish Maheshwari’s BAT VC announced a $100 million fund for early-stage Indian startups. Kriscore Capital also marked the first close of its INR 100 Cr (~$11.7 Mn) fund, aimed at backing 16–18 tech startups.
On the M&A front, Capillary Technologies acquired Kognitiv, strengthening its global SaaS presence. Groww also agreed to acquire wealthtech startup Fisdom in an all-cash deal valued at $150 million, while Singapore’s GIC sought CCI’s nod to pick up a 2.1% stake in Groww.
Other Highlights: Dream11, Zepto, DroneAcharya
In other headline developments:
-
Dream11 announced a $50 million investment in Cricbuzz to deepen its cricket content and streaming play.
-
Motilal Oswal and Raamdeo Agrawal entered Zepto’s cap table via a $100 million secondary deal, further validating the quick-commerce unicorn’s growing appeal.
-
DroneAcharya and AITMC Ventures paused their merger talks, opting to explore individual market opportunities instead.
What Lies Ahead?
While this week marked a funding lull, foundational shifts in IPO plans, fund launches, and strategic acquisitions suggest that the ecosystem is actively preparing for its next growth spurt. As Indian startups mature and investor interest evolves, the coming weeks could bring a fresh wave of capital—albeit with sharper focus and greater discipline.
